CA3040513A1 - Comprime oral de cannabinoide - Google Patents
Comprime oral de cannabinoideInfo
- Publication number
- CA3040513A1 CA3040513A1 CA3040513A CA3040513A CA3040513A1 CA 3040513 A1 CA3040513 A1 CA 3040513A1 CA 3040513 A CA3040513 A CA 3040513A CA 3040513 A CA3040513 A CA 3040513A CA 3040513 A1 CA3040513 A1 CA 3040513A1
- Authority
- CA
- Canada
- Prior art keywords
- particles
- oral tablet
- tablet according
- oral
- tablet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
Abstract
La présente invention concerne un comprimé oral qui administre des cannabinoïdes aux muqueuses et dont la population comprend des particules et au moins un cannabinoïde. La population des particules comprend des particules de polyalcool directement compressibles (DC) ainsi que des particules de polyalcool non directement compressible (non DC) qui fournissent plusieurs zones non DC discrètes.
Priority Applications (21)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA3040513A CA3040513C (fr) | 2019-04-17 | 2019-04-17 | Comprime oral de cannabinoide |
MX2021012712A MX2021012712A (es) | 2019-04-17 | 2020-04-17 | Tabletas de cannabinoides de desintegracion rapida. |
PCT/DK2020/050102 WO2020211915A1 (fr) | 2019-04-17 | 2020-04-17 | Comprimés cannabinoïdes à désintégration rapide |
PL20727578.5T PL3920891T3 (pl) | 2019-04-17 | 2020-04-17 | Szybko rozpadające się tabletki kannabinoidowe |
EP20727578.5A EP3920891B1 (fr) | 2019-04-17 | 2020-04-17 | Comprimés de cannabinoïdes à désintégration rapide |
FIEP20726699.0T FI3920890T3 (fi) | 2019-04-17 | 2020-04-17 | Oraalinen kannabinoiditabletti |
ES20726699T ES2966539T3 (es) | 2019-04-17 | 2020-04-17 | Comprimido oral de cannabinoides |
DK20726699.0T DK3920890T3 (da) | 2019-04-17 | 2020-04-17 | Oral cannabinoid-tablet |
EP23196168.1A EP4268815A3 (fr) | 2019-04-17 | 2020-04-17 | Comprimés multimodulaires de cannabinoïdes |
AU2020259627A AU2020259627B2 (en) | 2019-04-17 | 2020-04-17 | An oral cannabinoid tablet |
CN202080029225.3A CN113784704A (zh) | 2019-04-17 | 2020-04-17 | 快速崩解大麻素片剂 |
EP23204541.9A EP4289423A3 (fr) | 2019-04-17 | 2020-04-17 | Comprimé oral de cannabinoïdes |
DK20727578.5T DK3920891T3 (da) | 2019-04-17 | 2020-04-17 | Hurtig desintegrerende cannabinoid-tabletter |
JP2021561780A JP2022529037A (ja) | 2019-04-17 | 2020-04-17 | 速崩壊カンナビノイド錠剤 |
AU2020258631A AU2020258631B2 (en) | 2019-04-17 | 2020-04-17 | Fast disintegrating cannabinoid tablets |
PL20726699.0T PL3920890T3 (pl) | 2019-04-17 | 2020-04-17 | Doustna tabletka kannabinoidowa |
CN202080029324.1A CN113710235B (zh) | 2019-04-17 | 2020-04-17 | 经口大麻素片剂 |
PCT/DK2020/050100 WO2020211913A1 (fr) | 2019-04-17 | 2020-04-17 | Comprimé cannabinoïde oral |
BR112021020523A BR112021020523A2 (pt) | 2019-04-17 | 2020-04-17 | Comprimidos de canabinoide de desintegração rápida |
EP20726699.0A EP3920890B1 (fr) | 2019-04-17 | 2020-04-17 | Comprimé oral de cannabinoïdes |
FIEP20727578.5T FI3920891T3 (fi) | 2019-04-17 | 2020-04-17 | Nopeasti hajoavat kannabinoiditabletit |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA3040513A CA3040513C (fr) | 2019-04-17 | 2019-04-17 | Comprime oral de cannabinoide |
Publications (2)
Publication Number | Publication Date |
---|---|
CA3040513A1 true CA3040513A1 (fr) | 2020-10-17 |
CA3040513C CA3040513C (fr) | 2021-08-24 |
Family
ID=72896209
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA3040513A Active CA3040513C (fr) | 2019-04-17 | 2019-04-17 | Comprime oral de cannabinoide |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA3040513C (fr) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022112949A1 (fr) * | 2020-11-25 | 2022-06-02 | Nicoventures Trading Limited | Produit cannabinoïde oral avec composant lipidique |
CN115644438A (zh) * | 2022-11-04 | 2023-01-31 | 中华全国供销合作总社济南果品研究所 | 一种含西洋参、无花果的提神益智含片及其制备方法 |
US11793230B2 (en) | 2019-12-09 | 2023-10-24 | Nicoventures Trading Limited | Oral products with improved binding of active ingredients |
WO2024008261A1 (fr) * | 2022-07-05 | 2024-01-11 | Fertin Pharma A/S | Prémélange de cannabinoïdes et de lipides |
US11896711B2 (en) | 2019-12-09 | 2024-02-13 | Nicoventures Trading Limited | Process of making nanoemulsion |
-
2019
- 2019-04-17 CA CA3040513A patent/CA3040513C/fr active Active
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11793230B2 (en) | 2019-12-09 | 2023-10-24 | Nicoventures Trading Limited | Oral products with improved binding of active ingredients |
US11896711B2 (en) | 2019-12-09 | 2024-02-13 | Nicoventures Trading Limited | Process of making nanoemulsion |
WO2022112949A1 (fr) * | 2020-11-25 | 2022-06-02 | Nicoventures Trading Limited | Produit cannabinoïde oral avec composant lipidique |
US11839602B2 (en) | 2020-11-25 | 2023-12-12 | Nicoventures Trading Limited | Oral cannabinoid product with lipid component |
WO2024008261A1 (fr) * | 2022-07-05 | 2024-01-11 | Fertin Pharma A/S | Prémélange de cannabinoïdes et de lipides |
CN115644438A (zh) * | 2022-11-04 | 2023-01-31 | 中华全国供销合作总社济南果品研究所 | 一种含西洋参、无花果的提神益智含片及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CA3040513C (fr) | 2021-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11903919B2 (en) | Oral cannabinoid tablet | |
CA3040513C (fr) | Comprime oral de cannabinoide | |
AU2020259627B2 (en) | An oral cannabinoid tablet | |
US20240065973A1 (en) | Tableted Cannabinoid Chewing Gum With Tableted Modules | |
US20220323349A1 (en) | Cannabinoid chewing gum with high intensity sweeteners | |
US10933017B2 (en) | Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers | |
US11471405B2 (en) | Tableted chewing gum with enhanced delivery of cannabinoids | |
US11253473B2 (en) | Method of producing tableted cannabinoid chewing gum | |
EP3876744B1 (fr) | Gomme à mâcher à base de cannabinoïdes en comprimés à structure stratifiée | |
US11154496B2 (en) | Cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers | |
US11166910B2 (en) | Cannabinoid chewing gum with sugar alcohols | |
CA3035390C (fr) | Gomme a macher en tablette avec administration amelioree de cannabin oides | |
AU2019433058B2 (en) | Tableted cannabinoid chewing gum with improved release | |
CN113329743B (zh) | 具有聚乙酸乙烯酯弹性体增塑剂的压片大麻素口香糖 | |
CA3035400C (fr) | Gomme a macher en tablette contenant des cannabinoides en couches | |
CA3035381C (fr) | Gomme a macher en tablette contenant des cannabinoides avec liberati on amelioree | |
US20200276118A1 (en) | Tableted cannabinoid chewing gum with improved release | |
US20240008514A1 (en) | Cannabinoid Lipid Premixture | |
EP3930696A1 (fr) | Gomme à mâcher en comprimés à administration améliorée de cannabinoïdes | |
CA3035409A1 (fr) | Gomme a macher en tablette contenant des cannabinoides ayant des plas tifiants elastomeres de poly(acetate de vinyle) |